Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 705-714

  Supply, Philip ^a   Sutton, Philip ^a   Coughlan, Susie N ^b   Bilo, Katja ^b   Saman, Eric ^c   Trees, Alexander J ^b   Cesbron Delauw, Marie France ^a   Locht, Camille ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c INNOGENETICS   (Belgium)

Author keywords

Gra1; Recombinant BCG; T. gondii vaccine

Indexed keywords

BCG VACCINE; RECOMBINANT VACCINE; TOXOPLASMA GONDII VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP; SUBCUTANEOUS DRUG ADMINISTRATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIGENS, PROTOZOAN; BCG VACCINE; FEMALE; MICE; RECOMBINANT FUSION PROTEINS; SHEEP; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, SYNTHETIC;

EID: 0033605234     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00255-2     Document Type: Article

References (38)

1. Blewett D.A., Trees A.J. The epidemiology of ovine toxoplasmosis with especial respect to control. Br Vet J. 143:1987;128-135.
2. Dubey J.P. Status of toxoplasmosis in sheep and goats in the United States. J Am Vet Med Assoc. 196:1990;259-262.
3. Roberts T., Frenkel J.K. Estimating economic losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc. 196:1990;249-256.
4. Luft B.J., Remington J.S. AIDS commentary: toxoplasmic encephalitis in AIDS. Clin Infect Dis. 15:1992;211-222.
5. Frenkel J.K. Pathophysiology of toxoplasmosis. Parasitol Today. 4:1988;273-278.
6. Buxton D., Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology. 110:1995;511-516.
7. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J Am Med Assoc. 271:1994;698-702.
8. Stover C.K., de la Cruz V.F., Fuerst T.R., Burlein J.E., Benson L.A., Bennet L.T., Bansal G.P., Young J.F., Lee M.H., Hatfull G.F., Snapper S.B., Barletta R.G., Jacobs Jr W.R., Bloom B.R. New use of BCG for recombinant vaccine. Nature. 351:1991;456-460.
9. Connell N.D., Medinaacosta E., McMaster W.R., Bloom B.R., Russell D.G. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci USA. 90:1993;11473-11477.
10. Langermann S., Palaszynski S., Sadziene A., Stover C.K., Koenig S. Systemic and mucosal immunity induced by BCG vector expressing an outer-surface protein of Borrelia burgdorferi. Nature. 372:1994;552-555.
11. Langermann S., Palaszynski S.R., Burlein J.E., Koenig S., Hanson M.S., Briles D.E., Stover C.K. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J Exp Med. 180:1994;2277-2286.
12. Darcy F., Deslee D., Santoro F., Charif H., Auriault C., Decoster A., Duquesne V., Capron A. Induction of a protective antibody- dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol. 10:1988;553-567.
13. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslée D., Godard I., Cesbron-Delauw M.-F., Tartar A., Capron A. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxopasma gondii P30 antigen. J Immunol. 149:1992;3636-3641.
14. Cesbron-Delauw M.-F., Guy B., Torpier G., Pierce R.J., Lenzen G., Cesbron J.-Y., Charif H., Lepage P., Darcy F., Lecocq J.-P., Capron A. Molecular characterization of a 23-kDa major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci USA. 86:1989;7537-7541.
15. Coughlan SN, Trees AJ. Unpublished observations.
16. Wiker H.G., Harboe M. The antigen-85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 56:1992;648-661.
17. Huygen K., Vanvooren J.-P., Turneer M., Bosmans R., Dierckx P., Debruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol. 27:1988;187-194.
18. Baulard A., Kremer L., Supply P., Vidaud D., Bidart J.M., Bellet D., Locht C. A new series of mycobacterial expression vectors for the development of live recombinant vaccines. Gene. 176:1996;149-154.
19. Kremer L., Baulard A., Estaquier J., Content J., Capron A., Locht C. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol. 177:1995;642-653.
20. Trees A.J., Crozier S., Buxton D., Blewett D. Serodiagnosis of ovine toxoplasmosis: an assessment of the latex agglutination test and the value of IgM specific titres after experimental oocyst-induced infections. Res Vet Sci. 46:1989;67-72.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
22. Sauton B. Sur la nutrition minérale du bacille tuberculeux. C R Acad Sci Paris. 155:1912;860.
23. Smith D.B., Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
24. Baulard A., Jourdan C., Mercenier A., Locht C. Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucl Acids Res. 20:1992;4105.
25. Bensadoun A., Weinstein D. Assay of proteins in the presence of interfering materials. Anal Biochem. 70:1976;241-250.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Harlow E, Lanes D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988.
28. Coughlan S.N., Saman E., Jacobs D., Mercier C., Cesbron M.-F., Trees A.J. Cellular and humoral immune responses to recombinant antigens in sheep infected with Toxoplasma gondii. Parasite Immunol. 17:1995;465-468.
29. Rothel J., Jones S., Corner L., Cox J., Wood P. A sandwich enzyme immunoassay for bovine interferon gamma and its use for the detection of tuberculosis in cattle. Aust Vet J. 67:1990;134-137.
30. Buxton D., Blewett D.A., Trees A.J., Mc Colgan C., Finlayson J. Further studies in the use of monensin in the control of experimental ovine toxoplasmosis. J Comp Path. 98:1988;225-236.
31. Buxton D., Thomson K., Maley S., Wright S., Bos H.J. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity when pregnant. Vet Rec. 128:1991;89-93.
32. McColgan C., Buxton D., Blewett D.A. Titration of Toxoplasma gondii oocysts in non-pregnant sheep and the effects of subsequent challenge during pregnancy. Vet Rec. 123:1988;467-470.
33. Kremer L., Riveau G., Baulard A., Capron A., Locht C. Antibody responses elicited in mice immunized with recombinant BCG producing the Schistosoma mansoni glutathione S-transferase. J Immunol. 156:1996;4309-4317.
34. Cesbron-Delauw M-F, Pierce RJ, Torpier G, Cesbron J-Y, Leite P, Darcy F, Capron A, Guy B, Lenzen G, Lecocq J-P. A strategy for cloning potential protective antigens of Toxoplasma gondii. In: Ginsberg H, Lerner RA, Chanock RM, Brown F, editors. Vaccines vol. 87. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989. p. 155.
35. Murray P.J., Aldovini A., Young R.A. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA. 93:1996;934-939.
36. Huygen K., Abramovic D., Vandenbussche P., Jacobs F., De Bruyn J., Kentos A., Drowart A., Van Vooren J.-P., Goldman M. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun. 60:1992;2880-2886.
37. Skamene E. Genetic regulation of resistance to mycobacterial infections. Curr Top Microbiol Immunol. 124:1986;49-66.
38. Charif H., Darcy F., Torpier G., Cesbron-Delauw M.F., Capron A. Toxoplasma gondii: characterization and localization of antigens from tachyzoites. Exp Parasitol. 71:1990;114-124.